Condensed Consolidated Statements of Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Operating expenses:
Research and development	$ 10,021	$ 5,842	$ 18,825	$ 10,842
General and administrative	3,268	2,540	6,370	5,103
Total operating expenses	13,289	8,382	25,195	15,945
Loss from operations	(13,289)	(8,382)	(25,195)	(15,945)
Other income (expense):
Interest income, net	935	1,207	1,933	2,428
Other (expense) income, net	(5)	153	(6)	318
Interest expense	(1)	(153)	(2)	(384)
Total other income, net	929	1,207	1,925	2,362
Loss before income taxes	(12,360)	(7,175)	(23,270)	(13,583)
Income tax benefit	8	30	16	37
Net loss	$ (12,352)	$ (7,145)	$ (23,254)	$ (13,546)
Basic net loss per common share outstanding	$ (0.12)	$ (0.07)	$ (0.23)	$ (0.14)
Diluted net loss per common share outstanding	$ (0.12)	$ (0.07)	$ (0.23)	$ (0.14)
Weighted average common shares used in net loss per share attributable to common stockholders, basic	101,041,573	98,698,579	100,279,393	98,654,868
Weighted average common shares used in net loss per share attributable to common stockholders, diluted	101,041,573	98,698,579	100,279,393	98,654,868
Net loss	$ (12,352)	$ (7,145)	$ (23,254)	$ (13,546)
Other comprehensive loss:
Net unrealized losses on available-for-sale marketable securities	(17)	(160)	(55)	(126)
Comprehensive loss	$ (12,369)	$ (7,305)	$ (23,309)	$ (13,672)